Gemcitabine and bendamustine is a safe and effective salvage regimen for patients with recurrent/refractory Hodgkin lymphoma: Results of a phase 1/2 study
| Image |  |
|---|---|
| Description | scientific article published on 10 December 2019 |
| Author/s |
author: Kristie A Blum Christopher R Flowers Jonathon B Cohen |
| Publication date | December 10, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |